| Catalog No. | Size | Price (USD) |
| 101500-T10-50 | 50 µL | $147.96 |
| 101500-T10-100 | 100 µL | $251.64 |
| 101500-T10-200 | 200 µL | $355.32 |
General Information
| Product name | Anti-Cyclin B2 Antibody, Rabbit Polyclonal |
| Validated applications | IHC-P (FAQ Protocol), ICC/IF (FAQ Protocol) |
| Species reactivity | Reacts with: Human |
| Specificity | Human Cynomolgus (Species predicted to react based on 100% sequence homology) |
| Immunogen | A synthetic peptide corresponding to the N-terminus of the Human cyclin B2/CCNB2 |
| Preparation | Produced in rabbits immunized with a synthetic peptide corresponding to the N-terminus of the Human cyclin B2/CCNB2, and purified by antigen affinity chromatography. |
| Source | Polyclonal Rabbit IgG |
| Purification | Protein A & Antigen Affinity |
| Formulation | 0.2 μm filtered solution in PBS |
| Conjugate | Unconjugated |
| Form | Liquid |
| Shipping | This antibody is shipped as liquid solution at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
| Storage | This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles. |
Synonyms: Anti-HsT17299 Antibody
Image / Experimental Information
| Image 1 Description | Immunochemical staining of human CCNB2 in human adrenal gland with rabbit polyclonal antibody (1:1000, formalin-fixed paraffin embedded sections). |
| Image 1 Alt Text | Human cyclin B2/CCNB2 Immunohistochemistry(IHC) 18192 |
| Image 1 URL | Source image |
| Image 2 Description | Immunochemical staining of human CCNB2 in human adrenal gland with rabbit polyclonal antibody (1:1000, formalin-fixed paraffin embedded sections). |
| Image 2 Alt Text | Human cyclin B2/CCNB2 Immunofluorescence(IF) 18193 |
| Image 2 URL | Source image |
Background Information
| Full Name | cyclin B2 |
| Description | Cyclin B2 (CCNB2), a member of cyclin family proteins, serves a key role in progression of G2/M transition. CCNB2 protein is associated with clinical progression and poor prognosis in NSCLC. Cyclin B2 (CCNB2), a member of the cyclin protein family, has been found to be up-regulated in human cancers. Detection of serum circulating CCNB2 mRNA may have potential clinical applications in screening and monitoring of metastasis and therapeutic treatments. |
-HD09SE1010-1ug-adrenal-gland-IHC-P.png){kind=link}
-HD09SE1010-1000-SW480-IF.png){kind=link}